Comments
UK-based GlaxoSmithKline Plc will examine selling its stake in the Indian consumer health subsidiary to fund its $13-billion Novartis deal, says a Bloomberg report. The strategic review of its 72.5 per cent stake in GlaxoSmithKline Consumer Healthcare is expected to be closed by 2018 end. Brand Horlicks will also be part of the process, GSK said. However, there can be no assurance that the review process will result in any transaction, the pharma major further clarified.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.